Study is based on the incidence of CD20 in B-cell lymphoma and evaluation expression of CD20 protein on paraffin embedded tissue sections by Immunohistochemical analysis in B-cell lymphoma. Immunohistochemical analysis is advantageous because the antigen expression can be studied within the cancer cells.
Correlate CD20 expression with established clinico-pathological parameters, and understanding antiCD20 therapy on B-cell lymphoma patients. It was assumed that data from the present study would provide better insight in to the role of CD20 in B-cell lymphoma patients, and further help in treatment planning of these patients.
Key words : lymphocytes, Immunohistochemical, B-cells, Chemotherapy